Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-12

Clinical Trial Update: Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis [NA]

View source ↗

Summary

A clinical trial investigates whether retaining vernix caseosa in newborns could help prevent atopic dermatitis, and the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Atopic Dermatitis | NA | Status: NOT_YET_RECRUITING